Atom | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Funder: National Institutes of Health (NIH)

Due Dates: October 21, 2024 (Final Application Deadline)

Funding Amounts: Direct costs up to $499,000/year; total up to $750,000 over 3 years. Project period up to 3 years (R61 up to 2 years, R33 up to 2 years).

Summary: Supports development and validation of animal and ex vivo models of neurological or neuromuscular disorders to improve translational relevance for neurotherapeutic discovery.

Key Information: Uses phased R61/R33 award mechanism; clinical trials not allowed; requires clear go/no-go milestones for phase transition; encourages multidisciplinary and diverse teams.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Sign in to see full grant listing